RESUMEN
Patients with intestinal fat malabsorption and urolithiasis are particularly at risk of acquiring fat-soluble vitamin deficiencies. The aim of the study was to evaluate the vitamin status and metabolic profile before and after the supplementation of fat-soluble vitamins A, D, E and K (ADEK) in 51 patients with fat malabsorption due to different intestinal diseases both with and without urolithiasis. Anthropometric, clinical, blood and 24-h urinary parameters and dietary intake were assessed at baseline and after ADEK supplementation for two weeks. At baseline, serum aspartate aminotransferase (AST) activity was higher in stone formers (SF; n = 10) than in non-stone formers (NSF; n = 41) but decreased significantly in SF patients after supplementation. Plasma vitamin D and E concentrations increased significantly and to a similar extent in both groups during intervention. While plasma vitamin D concentrations did not differ between the groups, vitamin E concentrations were significantly lower in the SF group than the NSF group before and after ADEK supplementation. Although vitamin D concentration increased significantly in both groups, urinary calcium excretion was not affected by ADEK supplementation. The decline in plasma AST activity in patients with urolithiasis might be attributed to the supplementation of ADEK. Patients with fat malabsorption may benefit from the supplementation of fat-soluble vitamins ADEK.
Asunto(s)
Síndromes de Malabsorción/sangre , Urolitiasis/sangre , Vitamina A/sangre , Vitamina D/sangre , Vitamina E/sangre , Vitamina K/sangre , Adulto , Anciano , Aspartato Aminotransferasas/sangre , Colesterol/sangre , Suplementos Dietéticos , Femenino , Humanos , Síndromes de Malabsorción/complicaciones , Síndromes de Malabsorción/terapia , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Triglicéridos/sangre , Urolitiasis/complicaciones , Urolitiasis/terapia , Vitamina A/administración & dosificación , Deficiencia de Vitamina A/sangre , Deficiencia de Vitamina A/etiología , Deficiencia de Vitamina A/terapia , Vitamina D/administración & dosificación , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/etiología , Deficiencia de Vitamina D/terapia , Vitamina E/administración & dosificación , Deficiencia de Vitamina E/sangre , Deficiencia de Vitamina E/etiología , Deficiencia de Vitamina E/terapia , Vitamina K/administración & dosificación , Deficiencia de Vitamina K/sangre , Deficiencia de Vitamina K/etiología , Deficiencia de Vitamina K/terapia , Vitaminas/administración & dosificación , Vitaminas/sangreRESUMEN
PURPOSE: The purpose of this case study is to raise awareness about an uncommon cause of knee pain. DATA SOURCES: Review of literature was done using PubMed, CINAHL, and Medline. There was no limitation placed on the publication year. Only articles written in English were included. CONCLUSION: Knee pain is a common diagnosis that many healthcare providers see on a daily basis in their practice. Musculoskeletal injury or trauma is most commonly identified as the cause of this symptom. However, there are rare instances in which an unexpected finding in a client's history and physical exam lead us to an unexpected cause, such as abetalipoproteinemia. Abetalipoproteinemia is a rare autosomal recessive disorder in which an affected individual does not absorb lipids or the lipid-soluble vitamins A, D, E, and K. Multiple body systems are impacted by this fat malabsorption and resultant vitamin deficiencies. Without corrective supplementation, clinical manifestations which are directly related to the vitamin deficiencies will appear as presented in this case study-knee pain. IMPLICATIONS FOR PRACTICE: This case study emphasizes the need for nurse practitioners to seek out opportunities to further our knowledge which will enhance our clinical expertise as well as the quality of the health care we provide to our clients.
Asunto(s)
Abetalipoproteinemia/complicaciones , Artralgia/etiología , Articulación de la Rodilla , Deficiencia de Vitamina E/complicaciones , Abetalipoproteinemia/terapia , Artralgia/terapia , Femenino , Humanos , Deficiencia de Vitamina E/terapia , Adulto JovenRESUMEN
Vitamin E is the most important chain-breaking, lipid-soluble antioxidant present in body tissues of all cells and is considered the first line of defense against lipid peroxidation and it is important for normal function of the immune cells. However, vitamin E deficiency is rare in well-nourished healthy subjects and is not a problem, even among people living on relatively poor diets, both T- and B-cell functions are impaired by vitamin E deficiency. While immune cells are particularly enriched in vitamin E because of their high polyunsaturated fatty acid content, this point puts them at especially high risk for oxidative damage. Besides its immunomodulatory effects, vitamin E also plays an important role in carcinogenesis with its antioxidant properties against cancer, and ischemic heart disease with limiting the progression of atherosclerosis. Supplementation of vitamin E significantly enhances both cell mediated and humoral immune functions in humans, especially in the elderly and animals.
Asunto(s)
Inmunidad , Vitamina E/fisiología , Animales , Humanos , Enfermedades del Sistema Inmune/dietoterapia , Enfermedades del Sistema Inmune/tratamiento farmacológico , Enfermedades del Sistema Inmune/etiología , Inmunidad/efectos de los fármacos , Inmunomodulación/efectos de los fármacos , Vitamina E/administración & dosificación , Vitamina E/uso terapéutico , Deficiencia de Vitamina E/inmunología , Deficiencia de Vitamina E/fisiopatología , Deficiencia de Vitamina E/terapiaRESUMEN
Nutritional deficiencies have always been a major consideration in pediatrics. Although the classic forms of many of the well-documented nutritional deficiencies are memorized during training as a physician, nutritional deficiencies that can occur in otherwise asymptomatic normally growing children are often overlooked. The two most common deficiencies seen in children who are growing normally are iron and vitamin D deficiencies. These deficiencies are surprisingly common and can have a significant impact on the overall health of a child. This article reviews these nutritional deficiencies and other less commonly seen deficiencies in children who are otherwise growing normally.
Asunto(s)
Avitaminosis/diagnóstico , Avitaminosis/terapia , Desarrollo Infantil , Desnutrición/diagnóstico , Desnutrición/terapia , Oligoelementos/deficiencia , Anemia Ferropénica/diagnóstico , Anemia Ferropénica/terapia , Deficiencia de Ácido Ascórbico/diagnóstico , Deficiencia de Ácido Ascórbico/terapia , Avitaminosis/dietoterapia , Avitaminosis/tratamiento farmacológico , Calcio/deficiencia , Niño , Cobre/deficiencia , Humanos , Fórmulas Infantiles/química , Fórmulas Infantiles/normas , Yodo/deficiencia , Desnutrición/dietoterapia , Desnutrición/tratamiento farmacológico , Raquitismo/diagnóstico , Raquitismo/terapia , Selenio/deficiencia , Estados Unidos , Deficiencia de Vitamina A/diagnóstico , Deficiencia de Vitamina A/terapia , Deficiencia de Vitamina B/diagnóstico , Deficiencia de Vitamina B/terapia , Deficiencia de Vitamina D/diagnóstico , Deficiencia de Vitamina D/terapia , Deficiencia de Vitamina E/diagnóstico , Deficiencia de Vitamina E/terapia , Deficiencia de Vitamina K/diagnóstico , Deficiencia de Vitamina K/terapia , Zinc/deficienciaRESUMEN
Brown bowel syndrome is characterized by deposits of lipofuscin in the tunica muscularis of the small intestine. Its etiology is associated with chronic malabsorption resulting in a deficiency of vitamin E. This hypovitaminosis is believed to cause a mitochondrial myopathy secondary to loss of the antioxidant properties of vitamin E, which further worsens the malabsorption and leads to atonic, dilated segments of bowel. Current treatment options involve nutritional supplementation, surgical resection of the affected segments, and intestinal transplantation.
Asunto(s)
Íleon/metabolismo , Lipofuscina/metabolismo , Síndromes de Malabsorción/complicaciones , Deficiencia de Vitamina E/etiología , Adulto , Femenino , Humanos , Síndromes de Malabsorción/fisiopatología , Síndromes de Malabsorción/terapia , Síndrome , Deficiencia de Vitamina E/fisiopatología , Deficiencia de Vitamina E/terapiaRESUMEN
Ataxia with vitamin E deficiency (AVED) is a rare autosomal recessive neurodegenerative disorder due to mutations in the alpha-tocopherol transfer protein (TTPA) gene on chromosome 8q13. AVED patients have progressive spinocerebellar symptoms and markedly reduced plasma levels of vitamin E. We studied neurological phenotype at diagnosis, and long-term effect of vitamin E supplementation in 16 patients from 12 Italian families. The most common mutations were the 744delA and 513insTT. Two novel TTPA mutations were identified: a severe truncating mutation (219insAT) in a homozygous patient, and a Gly246Arg missense mutation (G246R) in a compound heterozygous patient. The missense mutation was associated with a mild and slowly progressive form of the disease. Vitamin E supplementation therapy allowed a stabilization of the neurological conditions in most of the patients. However, development of spasticity and retinitis pigmentosa was noted in a few patients during therapy. Prompt genetic characterization of AVED patients may allow an effective early treatment and an adequate genetic counseling.
Asunto(s)
Ataxia/genética , Proteínas Portadoras/genética , Mutación , Fenotipo , Deficiencia de Vitamina E/genética , Adolescente , Adulto , Ataxia/diagnóstico , Ataxia/terapia , Femenino , Estudios de Seguimiento , Humanos , Italia , Masculino , Persona de Mediana Edad , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/genética , Enfermedades del Sistema Nervioso/terapia , Linaje , Vitamina E/uso terapéutico , Deficiencia de Vitamina E/diagnóstico , Deficiencia de Vitamina E/terapiaRESUMEN
The mnd mouse, a model of neuronal ceroid lipofusinosis (NCL), has a profound vitamin E deficiency in sera and brain, associated with cerebral deterioration characteristic of NCL. In this study, the vitamin E deficiency is corrected using dietary supplementation. However, the histopathological features associated with NCL remained. With use of a bioinformatics approach based on high-resolution solid and solution state 1H-NMR spectroscopy and principal component analysis (PCA), the deficits associated with NCL are defined in terms of a metabolic phenotype. Although vitamin E supplementation reversed some of the metabolic abnormalities, in particular the concentration of phenylalanine in extracts of cerebral tissue, PCA demonstrated that metabolic deficits associated with NCL were greater than any effects produced from vitamin E supplementation. These deficits included increased glutamate and N-acetyl-L-aspartate and decreased creatine and glutamine concentrations in aqueous extracts of the cortex, as well as profound accumulation of lipid in intact cerebral tissue. This is discussed in terms of faulty production of mitochondrial-associated membranes, thought to be central to the deficits in mnd mice.
Asunto(s)
Biología Computacional/métodos , Lipofuscinosis Ceroideas Neuronales/metabolismo , Deficiencia de Vitamina E/metabolismo , Animales , Encéfalo/metabolismo , Encéfalo/patología , Corteza Cerebral/química , Suplementos Dietéticos , Espectroscopía de Resonancia Magnética , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos C57BL , Ratones Mutantes Neurológicos , Lipofuscinosis Ceroideas Neuronales/sangre , Lipofuscinosis Ceroideas Neuronales/patología , Fenotipo , Análisis de Componente Principal , Vitamina E/administración & dosificación , Vitamina E/análisis , Vitamina E/uso terapéutico , Deficiencia de Vitamina E/terapiaRESUMEN
Proper vitamin nutrition is essential for all people but especially for elderly persons, because they are at higher risk for deficiency than younger adults. A review of the clinical effects of vitamin deficiency shows how easily deficiency can masquerade as other morbidities, such as skin, neurologic, and gait abnormalities. Given the numerous readily available forms and sources of supplementation, their low cost, and their rather limited potential for harm, the goal of good vitamin nutrition for the elderly is easily attainable. To be successful in this goal, physicians must look for patients at risk and for those with features of frank vitamin deficiency. Laboratory testing is most helpful with respect to vitamin B12 and folate deficiency. Given the great value of clinical assessment, the low cost of vitamins, and the higher cost of laboratory testing, the authors do not recommend testing before instituting multivitamin use or extra supplementation with individual vitamins unless the diagnosis of deficiency is in question or the use of supplementation would put the patient at risk. The authors' general recommendations are * one multivitamin daily * extra vitamin E for patients with cardiovascular risk factors or Alzheimer's dementia * extra vitamin D for patients with known osteoporosis, osteoporosis risk factors, or strong risk factors for vitamin D deficiency * extra folate for patients with cardiovascular risk factors (especially smokers) and alcoholics * extra thiamine for alcoholics.
Asunto(s)
Avitaminosis/epidemiología , Evaluación Nutricional , Vitaminas , Anciano , Deficiencia de Ácido Ascórbico/complicaciones , Deficiencia de Ácido Ascórbico/terapia , Avitaminosis/etiología , Avitaminosis/terapia , Suplementos Dietéticos , Deficiencia de Ácido Fólico/terapia , Evaluación Geriátrica , Humanos , Política Nutricional , Necesidades Nutricionales , Medición de Riesgo , Deficiencia de Vitamina A/complicaciones , Deficiencia de Vitamina A/terapia , Deficiencia de Vitamina B/complicaciones , Deficiencia de Vitamina B/terapia , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/terapia , Deficiencia de Vitamina E/complicaciones , Deficiencia de Vitamina E/terapia , Vitaminas/farmacología , Vitaminas/fisiología , Vitaminas/uso terapéuticoRESUMEN
In order to evaluate the effects of a necrogenic dose of diethylnitrosamine (DEN) on vitamin E-deficient and vitamin E-supplemented rats, a single dose of the drug (200 mg/kg body weight) was injected intraperitoneally at the end of 10 weeks of treatment with the diets. The hepatic necrosis and lipoperoxidation provoked by DEN were evaluated 24, 48, 72 and 120 hours after the injection and were found to be more intense in the deficient group (thiobarbituric acid reactive substances (TBARS): 5.20 +/- 1.48 nmol/mg protein; necrosis volume: 68.99 +/- 8.36%; P < 0.05) during the second period. Also, in the same group and during the same period, mean plasma and hepatic vitamin E concentrations and mean liver glutathione concentration were the lowest detected, suggesting the occurrence of antioxidant consumption due to the toxic action of DEN. In contrast to vitamin E deficiency, which permitted the drug to exert stronger toxic effects, 20-fold supplementation with vitamin E did not provide additional protection against the lipoperoxidation and necrosis provoked by DEN (P < 0.05). The results suggest that other mechanisms in addition to lipoperoxidation provoked by free radicals originating from the metabolism of nitrosamines by the cytochrome P-450-dependent enzymatic system may be involved in the hepatotoxic action of these substances.
Asunto(s)
Carcinógenos/toxicidad , Dietilnitrosamina/toxicidad , Hígado/efectos de los fármacos , Deficiencia de Vitamina E/etiología , Vitamina E/farmacología , Animales , Carcinógenos/administración & dosificación , Sistema Enzimático del Citocromo P-450/metabolismo , Dieta , Dietilnitrosamina/administración & dosificación , Radicales Libres , Glutatión/análisis , Glutatión/metabolismo , Inyecciones Intraperitoneales , Peroxidación de Lípido/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Masculino , Necrosis , Ratas , Ratas Wistar , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Vitamina E/sangre , Deficiencia de Vitamina E/terapiaRESUMEN
UNLABELLED: Natural Killer (NK) cell activity was examined in a 16-month-old Japanese boy with Shwachman syndrome associated with severe vitamin E deficiency. As evaluated by 51Cr-release assay from K562 cells, NK cell activity was constantly decreased. After 8 weeks of oral alpha-tocopherol (alpha-Toc) supplementation (100 mg/day), NK cell activity had normalised. When alpha-Toc supplementation was interrupted for 16 weeks. NK cell activity again decreased. Flow cytometry of peripheral lymphocytes revealed a lowered number of CD16+ CD 56- fraction, which has the most potent NK cell activity. Single cell-in-agarose assay, to investigate the binding and cytolytic activity of NK cell at the single cell level, revealed that the number of NK cells which bind to K562 cell was decreased, but that the cytolytic activity of the individual binding cell was relatively unaffected. A second supplementation of alpha-Toc for 8 weeks successfully restored NK cell activity, the number of cells expressing NK cell markers and the number of K562-binding cells as compared to the age-matched normal range. CONCLUSION: These results indicate that severe vitamin E deficiency caused impaired NK cell activity due to a decrease in the number of CD16+ CD56- NK cells and that this abnormality is reversible with alpha-Toc supplementation.
Asunto(s)
Enfermedades de la Médula Ósea/congénito , Células Asesinas Naturales/metabolismo , Deficiencia de Vitamina E/fisiopatología , Vitamina E/uso terapéutico , Adolescente , Enfermedades de la Médula Ósea/fisiopatología , Antígeno CD56/metabolismo , Humanos , Interleucina-2/metabolismo , Masculino , Receptores de IgG/metabolismo , Síndrome , Deficiencia de Vitamina E/terapiaRESUMEN
UNLABELLED: The aim of this study was to evaluate to what extent serum vitamins A and E cystic fibrosis are affected by the underlying disease, pancreatic sufficiency or insufficiency, meconium ileus, nutritional status, age and treatment (enzyme and vitamin supplementation). Serum vitamin A and E levels were determined by high performance liquid chromatography in 210 cystic fibrosis patients, subdivided according to clinical condition into four subgroups (unsupplemented pancreatic insufficiency, supplemented meconium ileus, pancreatic sufficiency, supplemented pancreatic insufficiency) and compared with 42 control subjects. Vitamin A and E levels were generally lower in cystic fibrosis patients than in controls (P < 0.002 and P < 0.001 respectively). Subjects with pancreatic insufficiency regularly receiving enzyme and vitamin supplementation had significantly lower vitamin A (P < 0.05) and vitamin E (P < 0.01) levels than controls. In subjects with pancreatic sufficiency only vitamin A was significantly lower than in controls (P < 0.01). Vitamin levels were not age-dependent in cystic fibrosis, and no significant correlation with standardized body weight (Z-score) was observed. CONCLUSION: Cystic fibrosis patients show a clear tendency to vitamin A and E deficiency, irrespective of pancreatic function, body weight and standardized supplementation with pancreatic extract and liposoluble vitamins. Since the clinical significance of this deficiency is still not clear, longitudinal studies of cystic fibrosis patients with and without adequate vitamin supplementation are required.
Asunto(s)
Fibrosis Quística/fisiopatología , Insuficiencia Pancreática Exocrina/fisiopatología , Extractos Pancreáticos/administración & dosificación , Deficiencia de Vitamina A/fisiopatología , Vitamina A/administración & dosificación , Deficiencia de Vitamina E/fisiopatología , Vitamina E/administración & dosificación , Adolescente , Adulto , Niño , Preescolar , Terapia Combinada , Fibrosis Quística/genética , Fibrosis Quística/terapia , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Insuficiencia Pancreática Exocrina/genética , Insuficiencia Pancreática Exocrina/terapia , Femenino , Humanos , Lactante , Masculino , Deficiencia de Vitamina A/genética , Deficiencia de Vitamina A/terapia , Deficiencia de Vitamina E/genética , Deficiencia de Vitamina E/terapiaRESUMEN
Children deficient in vitamin E have various neurologic symptoms. 2 cases representing different mechanisms of this vitamin deficiency are reported. A 15-year-old boy with fat malabsorption due to cystic fibrosis who was diagnosed as being vitamin E deficient (< 0.5 mg/l), had typical neuropathies. On the other hand, a 12-year-old Beduin girl had isolated vitamin E deficiency, as well as neurological symptoms suggestive of Friedrich's ataxia. Vitamin E supplementation by intramuscular injection in the first case and per os in the second led to significant improvement in neurological symptoms.
Asunto(s)
Enfermedades del Sistema Nervioso/etiología , Deficiencia de Vitamina E/complicaciones , Adolescente , Niño , Femenino , Ataxia de Friedreich/etiología , Humanos , Masculino , Vitamina E/uso terapéutico , Deficiencia de Vitamina E/terapiaRESUMEN
Oral vitamin E (Vit.E) bioavailability is reduced in CF patients especially in case of malnourishment. Both exocrine pancreatic insufficiency and an altered bile acid composition showing an elevated glycine taurine ratio of conjugated bile acids which is due to excessive loss of bile acids in the stools may contribute to this observation. Because taurine supplementation reduces the glycine/taurine ratio of bile acids in duodenal juice of CF-patients it was the objective of this study to evaluate the effect of taurine supplementation on Vit.E absorption kinetics. Oral Vit.E tolerance tests (50 mg/kg) were performed before and after 3 months of taurine supplementation (30 mg/kg/day) in 11 CF patients (ages 7 to 22 years) under fasting conditions. Bodyweight and or weight for height of all patients were below the 25th percentile. Doses of all medications except antibiotics were kept unchanged during the study. Any additional Vit.E supplementation was stopped 14 days prior to each test. Serum Vit.E levels were measured over a 24 hour period. Determination of serum Vit.E concentrations was performed with a HPLC fluorescence technique. The glycine/taurine ratio in serum served as compliance parameter and dropped in all but one patients. Baseline Vit.E concentrations and serum Vit.E/total lipids ratios in serum considered as parameters of the Vit.E status increased significantly. Both the maximal Vit.E concentrations in serum and the areas under the oral absorption curves showed a significant increase with taurine supplementation. This study shows that the Vit.E status of malnourished CF patients can be improved with taurine supplementation due to improved Vit.E absorption kinetics.(ABSTRACT TRUNCATED AT 250 WORDS)